These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 22025137)
1. Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy. Ouedraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P Eur J Cancer Prev; 2011 Nov; 20(6):462-74. PubMed ID: 22025137 [TBL] [Abstract][Full Text] [Related]
2. Attending breast cancer screening alone does not explain the detection of tumours at an early stage. Ouédraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P Eur J Cancer Prev; 2013 Mar; 22(2):103-11. PubMed ID: 22751208 [TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
4. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France). Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147 [TBL] [Abstract][Full Text] [Related]
5. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany]. Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967 [TBL] [Abstract][Full Text] [Related]
6. [Cancer of the breast in Cote-d'Or (1982-1987). The Burgundian register of gynecologic diseases]. Chaplain G; Cuisenier J; Le Dorze C; Pansiot F; Bastien H Bull Cancer; 1990; 77(1):5-14. PubMed ID: 2317576 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer screening in women aged 50-74 years: is there room for improvement? Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683 [TBL] [Abstract][Full Text] [Related]
8. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection? Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884 [TBL] [Abstract][Full Text] [Related]
9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG; Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112 [TBL] [Abstract][Full Text] [Related]
10. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases. Seigneurin A; Exbrayat C; Labarère J; Delafosse P; Poncet F; Colonna M Breast Cancer Res Treat; 2011 May; 127(1):221-8. PubMed ID: 20809364 [TBL] [Abstract][Full Text] [Related]
11. [French screening program of breast cancer. Results from 5 districts (1989-1994)]. Séradour B; Allemand H; Schaffer P Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188 [TBL] [Abstract][Full Text] [Related]
12. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674 [TBL] [Abstract][Full Text] [Related]
13. [Breast self-examination also valuable in women participating in a screening programme]. Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066 [TBL] [Abstract][Full Text] [Related]
15. Mode of breast cancer detection: a study from the German part of the Maas-Rhine-EUREGIO. Schleicher UM; Ammon J Eur J Cancer Prev; 1998 Feb; 7 Suppl 1():S41-6. PubMed ID: 10866035 [TBL] [Abstract][Full Text] [Related]
16. Attending the breast screening programme after breast cancer treatment: a population-based study. de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800 [TBL] [Abstract][Full Text] [Related]
17. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or]. Coudert B; Chaplain G; Milan C; Janoray P Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857 [TBL] [Abstract][Full Text] [Related]
18. Potential impact of USPSTF recommendations on early diagnosis of breast cancer. Aragon R; Morgan J; Wong JH; Lum S Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591 [TBL] [Abstract][Full Text] [Related]
19. Associations in breast and colon cancer screening behavior in women. Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418 [TBL] [Abstract][Full Text] [Related]
20. [Using medical imaging for a comprehensive breast cancer screening program]. Dilhuydy MH Bull Cancer; 2009 Nov; 96(11):1071-86. PubMed ID: 19887333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]